跳至主要内容
临床试验/NCT06163092
NCT06163092招募中不适用

The Prevalence of Chronic Endometritis and Therapeutic Benefits of Antibiotics in Women With Unexplained Recurrent Miscarriage

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 175 人开始时间: 2024年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
175
试验地点
1
主要终点
the incidence of chronic endometritis in local women with unexplained recurrent miscarriage

研究概览

简要总结

The aim of the study is to estimate the incidence of CE, evaluate the endometrial microorganism of CE, and investigate the therapeutic benefits of antibiotics for women with unexplained recurrent miscarriage and CE.

详细描述

Eligible women, based on the inclusion and exclusion criteria, will be recruited from the miscarriage clinic in the Prince of Wales Hospital. Endometrial sampling (ES) will alternatively be conducted during mid-luteal phase. In natural cycles, all the subjects will have a daily urine test from day 9 of the menstrual cycle to identify the Luteinizing Hormone (LH) surge. The ES will be obtained precisely 7 days after LH surge. Endometrial samples will be obtained using a Pipelle sampler as an outpatient procedure. The endometrium will be divided into three aliquots. One will be fixed in 4% formalin for 24 hours, routinely processed and embedded in paraffin wax. One will be investigated by microbial culture for infectious agents and one will be sequenced to reveal the endometrial microbiota.

CE will be diagnosed either by the presence of plasma cells and changes in endometrial stromal cells identified using HE and IHC, or by the finding of infectious agents using microbial culture. The selection of antibiotics will be based on the type of infectious agents or empirical, doxycycline 100mg BD po. for 14 days, for women with negative microbial culture. Endometrial biopsy will be repeated at the same time point after antibiotic treatment for women with CE. For persistent subjects with negative culturing, ciprofloxacin 500mg, BD po., and metronidazole 400mg TDS po. for 14 days will be used. The treatment will be repeated for three courses at maximum for women with persistent CE according to their willingness.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with a history of 2 or more consecutive miscarriages before 24 weeks of gestation
  • Women aged 20-45 years old

排除标准

  • Uncorrected uterine anomalies, such as the septate or bicornuate uterus, fibroids (submucous/intramural)
  • Untreated hydrosalpinx
  • Antiphospholipid syndrome
  • Known clinical autoimmune disease
  • Undergoing immunotherapy
  • Abnormal thyroid function
  • Abnormal karyotyping of couples
  • Known immunodeficiency pathologies such as diabetes or HIV
  • Currently taking other antibiotics or other trial medications or TCM;
  • Currently or previously involved in other clinical trials with medication intake;
  • Those with active pelvic inflammatory disease or suspicion of infection etc.

结局指标

主要结局

the incidence of chronic endometritis in local women with unexplained recurrent miscarriage

时间窗: 31 January 2027

the incidence of chronic endometritis in local women with unexplained recurrent miscarriage

次要结局

  • Investigate the spectrum of endometrial microorganisms associated with chronic endometritis in this population(31 January 2027)
  • Assess the clinical pregnancy outcomes between cured CE group and non-CE group(31 January 2027)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chung Pui Wah Jacqueline

Associate Professor

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验